header logo image


Page 40«..1020..39404142..5060..»

Archive for the ‘Arthritis’ Category

Arthritis Foundation

Friday, January 10th, 2020

As a partner, you will help the Arthritis Foundation provide life-changing resources, science, advocacy and community connections for people with arthritis, the nations leading cause of disability. Join us today and help lead the way as a Champion of Yes.

Our Trailblazers are committed partners ready to lead the way, take action and fight for everyday victories. They contribute $2,000,000 to $2,749,000

Our Visionary partners help us plan for a future that includes a cure for arthritis. These inspired and inventive champions have contributed $1,500,00 to $1,999,999.

Our Pioneers are always ready to explore and find new weapons in the fight against arthritis. They contribute $1,000,000 to $1,499,999.

Our Pacesetters ensure that we can chart the course for a cure for those who live with arthritis. They contribute $500,000 to $999,000.

Our Signature partners make their mark by helping us identify new and meaningful resources for people with arthritis. They contribute $250,000 to $499,999.

Our Supporting partners are active champions who provide encouragement and assistance to the arthritis community. They contribute $100,000 to $249,999.

Go here to see the original:
Arthritis Foundation

Read More...

Manifestations of Inflammation and Pain Flares in Rheumatoid Arthritis – Rheumatology Advisor

Friday, January 10th, 2020

Flaresare common in patients with rheumatoid arthritis (RA), but many experiencediscordant inflammation and pain flares, according to study results publishedin BMC Rheumatology.

The study included patients from the Early RA Network (ERAN) cohort (n=719). The researchers assessed patients annually up to 11 years after presentation (3703 person-years of follow-up). The researchers defined flare events in 2 different ways, which were analyzed in parallel: Disease Activity Score-28 (DAS28) or pain flares. DAS28 flares satisfied Outcome Measures in Rheumatology (OMERACT) flare criteria: increases in DAS28 since the previous assessment (1.2 points if active RA or 0.6 points if inactive RA). Pain flares were defined as a 4.8-point worsening of Short Form Health Survey 36-Bodily Pain score.

Theresearchers analyzed the first documented episode of each DAS28 and pain flarefor each patient. They then used latent class analysis to determine subgroupswith DAS28 and pain flares and compared clinical courses between subgroups.

Afteranalyzing the results, the researchers found that 45% of patients experiencedDAS28 flares and 52% experienced pain flares. Flares were usually discordant,with 60% of patients with DAS28 flare not concurrently in pain flare and 64% ofpatients with pain flare not concurrently in DAS28 flare.

Theresearchers identified 3 distinct DAS28 subgroups: the first characterized byincreases intender/swollen joint count (14.4%); the second by increases in symptoms (13.1%);and the third, which displayed lower flare severity (72.5%). They alsoidentified 2 discrete pain flare subgroups: in the first the pain flare occurredfollowing low disease activity and symptoms (88.6%) and in the second occurredon the background of ongoing active disease and pain (11.4%).

WhileDAS28 and pain flares had observed differences, both were associated withincreased disability, which persisted after the flare.

Thestudy included several limitations. The researchers noted that assessments maynot have captured data during a flares peak, while pre-flare data may notreflect the patients best clinical status. In addition, missing data may haveinfluenced the study findings.

DAS28and pain flares are discrete entities indicative of differing underlyingmechanisms, but both have immediate patient impact and lead to longer termdisability. Identifying and understanding RA flare subgroups should guidetreatment, the researchers wrote.

Disclosure: Several study authors declared affiliations with thepharmaceutical industry. Please see the original reference for a full list ofauthors disclosures.

Reference

McWilliams DF, Rahman S, James RJE, et al. Disease activity flares and pain flares in an early rheumatoid arthritis inception cohort; characteristics, antecedents and sequelae. [published online November 18, 2019]. BMC Rheumatol. doi:10.1186/s41927-019-0100-9

Continued here:
Manifestations of Inflammation and Pain Flares in Rheumatoid Arthritis - Rheumatology Advisor

Read More...

Which Joints Are Most Affected by Arthritis? – Yahoo Lifestyle

Friday, January 10th, 2020

Like many diseases, arthritis is not a one-size-fits-all illness. To explain it in the easiest wayor in the most general termsthink of arthritis in two overarching categories. "As a broad classification, you have inflammatory versus non-inflammatory arthritis," explains Dr. Natalie Azar, rheumatologist and clinical assistant professor in the department of medicine at NYU Langone Health. "We don't categorize arthritis by the joints affected, but by inflammatory versus non-inflammatory." Osteoarthritisthe non-inflammatory kindis synonymous with wear and tear. (It's generally the kind that occurs as you get older.) Rheumatoid arthritisthe inflammatory kindis systemic and associated with autoimmune diseases.

Witthaya Prasongsin/Getty

Osteoarthritis most commonly affects the knees ("Think of how many people get knee replacements," Dr. Azar says), as well as the hips and hands. While it is genetic, and can be associated with trauma, like fractures. Obesity can also lead to osteoarthritis, since you're putting too much pressure on your joints, Dr. Azar explains. For people afflicted with osteoarthritis, there unfortunately aren't any FDA-approved medicines that can change the course of the disease. "We're still left treating symptoms," Dr. Azar says. Physical therapy can help strengthen jointsand taking Tylenol to ease pain and inflammation can offer short-term, immediate relief to those dealing with both types of arthritis.

Related: These Are the Best Supplements for People Living with Arthritis

Rheumatoid arthritis, on the other hand, can affect small or large jointstypically four or more. "It's symmetrical, so both sides of the body are involved," Dr. Azar says. "It's not just one knee, but both knees, or both wrists, or both joints of the hands. It's also associated with swelling, stiffness that lasts for more than an hour, and pain." Rheumatoid arthritis, she says, can also affect the kidney and lungsit's not just a joint disease. Fortunately, with rheumatoid arthritis, there are disease-modifying therapies (or anti-rheumatic drugs) that patients can take in order to put them into remission and reverse damage, Dr. Azar explains.

And while diet doesn't cause either type of arthritis, once you have it (regardless of type), eating an inflammatory diet can exacerbate the situation, Azar says; alcohol, processed sugars, and trans fats are the usual culprits. Following an anti-inflammatory diet full of fruits, vegetables, lean protein, and healthy fats may help boost the immune system, fight inflammation, and strengthen bones, the Arthritis Foundation says. Azar refers patients to the site for information and health tips on what to eat while living with arthritis, but she adds that the dietlike the diseaseis not one-size-fits all. Some people can't tolerate nightshade vegetables like tomatoes, eggplants, and potatoes, for example, so you just have to experiment and tailor your diet to see what makes you feel your best.

See the original post:
Which Joints Are Most Affected by Arthritis? - Yahoo Lifestyle

Read More...

Arthritis: Include this type fish in your diet to alleviate joint pain – Express

Friday, January 10th, 2020

Arthritis is an umbrella term for a number of conditions that cause swelling and tenderness in one or more of your joints.

The main symptoms of arthritis are joint pain and stiffness, which typically worsen with age.

Osteoarthritis and rheumatoid arthritis are the two most common types of arthritis, and, while these conditions cannot be cured, lifestyle interventions can be taken to alleviate joint pain associated with them.

Certain foods, for example, have been shown to contain anti-inflammatory properties, and fatty fish, such as salmon, mackerel, sardines and trout, are high in omega-3 fatty acids, which have shown to produce potent anti-inflammatory effects.

In one small study, 33 participants were fed either fatty fish, lean fish or lean meat four times each week.

After eight weeks, the fatty fish group had decreased levels of specific compounds related to inflammation.

Echoing these findings, an analysis of 17 studies found that taking omega-3 fatty acid supplements decreased joint pain intensity, morning stiffness, the number of painful joints and use of pain relievers in patients with rheumatoid arthritis.

READ MORE:Best supplements for joints: The anti-inflammatory supplement proven to relieve joint pain

Exercise may seem counterintuitive if you are in pain, but in addition to helping you lose weight, it can also help to reduce and prevent pain associated with arthritis.

As the NHS points out, exercise can also help:

As long as you do the right type and level of exercise for your condition, your arthritis won't get any worse, explains the health body.

It added: Combined with a healthy, balanced diet, regular exercise will help you lose weight and place less strain on your joints.

According to Versus Arthritis, the UK's largest charity dedicated to supporting people with arthritis, you should aim to do at least 30 minutes of exercise that makes us a bit short of breath five times a week.

Its also recommended that you spend 30 minutes a day on our feet, such as walking or climbing stairs, notes the charity.

If you have joint pain, start gently and gradually increase the length of time youre exercising. You can break this into smaller chunks if you need to, advises the health body.

It added: Doing five to ten minutes of exercise each day is important to keep your joints moving and your muscles strong.

As the NHS explains, if you have arthritis, carrying out tasks around the home can be a challenge, however, making some practical changes to your home and changing the way you work should make things easier.

Practical tips that could help include:

An occupational therapist can also help if you have severe arthritis that's affecting your ability to move around your home and carry out everyday tasks, such as cooking and cleaning, notes the health body.

They can advise about equipment you may need to help you live independently, and, depending on the exact nature of your condition, your GP may be able to refer you to an NHS occupational therapist, adds the health site.

Visit link:
Arthritis: Include this type fish in your diet to alleviate joint pain - Express

Read More...

Vitamin D deficiency symptoms: A lack of the vitamin may cause pain in this body part – Express

Friday, January 10th, 2020

Vitamin D is a fat-soluble vitamin that is naturally present in very few foods, and available as a dietary supplement. Vitamin D plays a role in insulin production and immune function. Although the amount of vitamin D adults get from their diets is often less than whats recommended, exposure to sunlight can make up the difference.

Research has found that vitamin D may play a significant role in joint health, and that low levels may increase ones risk of rheumatological conditions such as arthritis.

Several studies have found low blood levels of vitamin D in patients with osteoarthritis of the hip and knee.

In another study of more than 2,000 people, researchers found that vitamin D deficiency was strongly associated with a disabling symptoms among those with rheumatoid arthritis.

DONT MISS

Why does a lack of vitamin D affect bones?

Vitamin D helps the bones absorb calcium, which is vital to bone health.

The vitamin is also crucial for muscle movement, communication between nerves, and fighting inflammation.

According to the Arthritis Foundation, people who take oral steroids have a vitamin D deficiency twice as often as people who dont take them.

Oral steroids are a common treatment for people with arthritis.

What studies have said

In a study with Endocrinology and Metabolism, the link between vitamin D and rheumatoid arthritis was investigated.

The study concluded that vitamin D deficiency is highly prevalent in patients with rheumatoid arthritis and that vitamin D deficiency may be linked to disease severity in rheumatoid arthritis.

As vitamin D deficiency has been linked to diffuse musculoskeletal pain, these results have therapeutic implications vitamin D supplementation may be needed both for the prevention of osteoporosis as well as for pain relief in patients with rheumatoid arthritis.

In addition to helping prevent arthritis, getting enough vitamin D may also lower the risk for other autoimmune diseases like cancer, heart disease, type 2 diabetes, bone fractures, depression and the flu.

During winter its highly recommended to take vitamin D supplements.

Doctors recommend taking 800 to 1,000 IU of vitamin D a day. Other symptoms of a vitamin D deficiency include pain, infections, gastrointestinal problems, depression and weak bones.

Read the original post:
Vitamin D deficiency symptoms: A lack of the vitamin may cause pain in this body part - Express

Read More...

Secukinumab has Early and Sustained Efficacy on Enthesitis in Patients with Psoriatic Arthritis – Pharmacy Times

Friday, January 10th, 2020

Secukinumab has Early and Sustained Efficacy on Enthesitis in Patients with Psoriatic Arthritis

Enthesitis is inflammation of the entheses, the site where ligaments or tendons insert into the bones. Common locations for enthesitis include the bottom of the feet, the Achilles tendons, and the places where ligaments attach to the ribs, spine, and pelvis.2

Patients with enthesitis are known to have worse outcomes than patients without enthesitis. Using pooled data from the FUTURE 2 and 3 studies, a research team explored the use of secukinumab to limit enthesitis in patients with PsA.1

FUTURE was a phase 3 randomized, double-blind, placebo-controlled multicenter study that analyzed the 24- to 52-week efficacy, safety, and tolerability of subcutaneous secukinumab in prefilled syringes. Researchers used the Leeds Enthesitis Index (LEI) that consists of 6 sites: bilateral Achilles tendon insertions, medial femoral condyles, and lateral epicondyles of the humerus. Tenderness at each site is quantified by a number scale: 0 means nontender and 1 means tender.4

The post hoc analyses included the resolution of enthesis count (EC=0), median time to first resolution of enthesitis, and shift analysis of baseline EC (1, 2, or 3-6) to full resolution (FR) stable (similar or reduction of EC), or worse (EC > baseline).1

Sixty-five percent (466/712) of patients had baseline enthesitis. In the overall population, FR was achieved as early as week 16 in 65% (300 mg) and 56% (150 mg) versus 44% in the placebo group, with further improvements to 91% (300 mg) and 88% (150 mg) at week 104. The majority (89%) of patients without enthesitis at baseline maintained their status at week 104.3

In patients with EC of 1 or 2, shift analysis from baseline to week 24 showed that more patients achieved FR with secukinumab 300 mg and 150 mg versus placebo, whereas no difference between secukinumab and placebo was shown in patients with more severe symptoms with an EC of 3 to 6. Improvements in efficacy outcomes were similar in patients with or without enthesitis treated with secukinumab 300 mg.1

Secukinumab provided early and sustained resolution of enthesitis in patients with PsA over 2 years, the study authors noted.1 Secukinumab 300 mg provided higher resolution than 150 mg in patients with more severe baseline EC and showed similar overall efficacy in patients with or without enthesitis.

Reference

See the original post here:
Secukinumab has Early and Sustained Efficacy on Enthesitis in Patients with Psoriatic Arthritis - Pharmacy Times

Read More...

JIA Orofacial Pain Linked to Stress, Activity Limitations, Study Shows – Juvenile Arthritis News

Friday, January 10th, 2020

People withjuvenile idiopathic arthritis (JIA) who experienceorofacial pain pain in the mouth, face, and jaw have more stress, limitations on daily activities, disease activity, and systemic inflammation than those who do not, a study reports.

The study, Orofacial pain in juvenile idiopathic arthritis is associated with stress as well as psychosocial and functional limitations, was published in the journal Pediatric Rheumatology.

The hallmarks of JIA are swelling of the joints, pain, and stiffness, typically in the knees, hands, or feet. JIA can affect other joints as well, such as those that connect the jaw to the head, which are known as the temporomandibular joints (TMJ).

Up to 96% of children with JIA develop TMJ arthritis, where stiffness, crepitus (joint popping), and restricted mouth opening are often reported.

Chronic or recurrent pain and disability in children and adolescents can limit their ability to function and grow properly. Many of these patients refrain from going to school and avoid engaging in social activities due to the psychosocial stress and pain associated with the disorder.

To investigate the relationship between psychosocial stress, along with inflammatory activity, and pain and function of the jaw, a group of researchers in Sweden studied 45 JIA patients ages 6 to 16. Sixteen children without JIA were also included as controls.

A clinical assessment, including both a physical and a psychosocial component, was conducted on all participants by one dentist.

Pain intensity and pain-related disability were assessed with the Graded Chronic Pain Scale. Limitations to jaw function was evaluated using the Jaw Functional Limitation Scale.

A four-item Patient Health Questionnairewas used to assess depression and anxiety symptoms. The Pain Catastrophizing Scale was applied to determine the degree of catastrophizing (believing pain is worse than it is), and the 10-item Perceived Stress Scale was used to evaluate stress.

The Childhood Health Assessment Questionnaire was used to assess ability to conduct daily life activities among children with JIA, while the body-drawing part of the McGill Pain Questionnaire was used to record pain locations.

Finally, the team used the Juvenile Arthritis Disease Activity Score,which includes an active joint count, a physician global assessment, a parent global evaluation, and the erythrocyte sedimentation rate (an indicator of systemic inflammation).

Results showed a strong association between experiencing orofacial pain and stress. Among patients scoring higher (worse) than normal in perceived stress, eight out of ten had self-reported orofacial pain.

Orofacial pain also significantly correlated with pain-related disability, depression, pain catastrophizing, and limitations in daily activities.

The team then compared clinical and psychosocial factors of JIA patients who experienced jaw pain with those who did not.

Orofacial pain was significantly associated with pain intensity, maximum mouth opening, and limitations on jaw functioning. JIA patients with orofacial pain also had higher disease activity and systemic inflammation than those without such pain.

In contrast, neither depression nor pain catastrophizing were linked to orofacial pain.

This study indicates that orofacial pain in patients with JIA is associated with stress, psychological distress, jaw dysfunction and loss of daily living activities, the researchers said.Pain intensity seems to be the major aspect related to these factors. In addition, increased disease activity with more joint involvement seems to be an important factor contributing to orofacial pain in JIA.

Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where hes helping make medical science information more accessible for everyone.

Total Posts: 11

Jos is a science news writer with a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimers disease.

Visit link:
JIA Orofacial Pain Linked to Stress, Activity Limitations, Study Shows - Juvenile Arthritis News

Read More...

Why I Relate to ‘Survivor’ as Someone With Rheumatoid Arthritis – Yahoo Lifestyle

Friday, January 10th, 2020

I spent my summer watching Survivor. You know, the reality television show that shows people living in rugged, beautiful climates, taking part in challenges and voting each other off the island every few days. I was a fan when it started in 2000, but over the years, schedules and life turned my attention to other viewing pleasures.

Back then, I liked the beautiful settings and the intrigue among the cast members who were creating these intense relationships from living together in harsh circumstances and then back-stabbing those same people as part of the game. But what I really loved were the challenges. These usually took the form of giant obstacle courses, either on a sandy beach or in the ocean. Contestants swam, jumped, dug, wiggled and ran their way to winning rewards or immunity from being voted off. I liked to think about how I would do that and what skills I would bring to such fun.

Related: 10 'Hidden' Symptoms of Rheumatoid Arthritis We Don't Talk About

But this summer was different.

After years away from the show, this summer I found 34 seasons on Hulu and binged my way through season after season. I was able to do this because this summer a rheumatoid arthritis flare that included severe back pain and fatigue put me in bed with just a phone and a remote. I spent hours watching Survivor, drawn in by something internal and strong. At first, I wasnt sure what the lure was, but then it occurred to me.

I saw myself on that screen, except this time through the lens of my new reality.

When contestants would swim into the ocean, climb a ladder to retrieve a special key, then swim back, struggling to pull themselves on to a platform, I saw myself. I recognized that deep, unshakable fatigue, even though the genesis was different for them than for me.

When it rained for five days straight and their fire went out so they could only eat coconut in wet clothes, I recognized the despair on their faces from not knowing when this particular pain would end.

Related: 13 Things People Who Have to Give Themselves Shots Wish Others Understood

When a downcast contestant would dig deep and finish a challenge just when they needed the win, I found inspiration in my own battle for a win.

When their families showed up as a surprise reward, I wept from knowing how sustaining that unconditional love is and the hope it brings.

Yes, I saw myself in these Survivor contestants. No, I wasnt wearing a bathing suit on national TV or wrestling another person to try to win fishing gear, but I was in my own battle. It was a battle that included pain, despair, fatigue and hope. It was a battle that meant I had to will all my internal strength to be the victor. And as summer ended and my pain eased, I realized that I too, in my own reality, could call myself a Sole Survivor.

5 Tips for Success With Medical Cannabis

What Its Like When Doctors Blame You for Your Chronic Illness

8 Ways to Partner With Your Doctor and Take Charge of Your Healing

How I Took Walking for Granted

Read the original post:
Why I Relate to 'Survivor' as Someone With Rheumatoid Arthritis - Yahoo Lifestyle

Read More...

Doctors Missed Her RA Symptoms in Pregnancy. She Found a Way to Thrive Anyway – HealthCentral.com

Friday, January 10th, 2020

Brooke Baker was sleeping soundly one night in 2005 when suddenly she woke up with new and excruciating pain in both shoulders. "I remember it so well, and I had no idea what was going on," recalls the Oklahoma native, now 39. "The pain was like someone was injuring me, and I couldn't go back to sleep for hours."

In the agonizing days to come, a perplexed and frightened Baker swapped out her mattress and her pillow and would prop herself up to try and alleviate the unrelenting stabbing sensations.

I just thought, Well, it must be one of those things, she says. But then that thing moved to her elbows, the next week to her wrists, and a week later, to her hands. I had never had any pain issues, and this all made me feel so debilitated. Having such painful arms and hands was especially unfair. Baker had been a full-time music minister at church for three years, playing the piano.

Realizing the continuing torment was anything but random, she went to see her OB/GYN. After all, she was eight weeks into a miracle pregnancy at the time (shed been told shed never be able to have children). The last thing she needed was unexplainable pain.

When I said: Something's wrong, during that office visit, both the nurse and the male doctor I saw told me I should be grateful to be pregnant and basically to suck it up, she says. Baker vowed to find a new OB/GYN, which she did four months into her pregnancy. At that point the pain was in every joint, from her neck to her toes.

This doctor was a little gentler, he did really listen, but he was also a poor communicator, Baker says. Because her symptoms were suspicious, the doctor did refer her to a local rheumatologist who ran some tests to confirm or rule out the possibility of rheumatoid arthritis (RA). That was the first mention that this disease could be the cause of her pain.

The rheumatologist later called me to report the results showed nothing, Baker says. Later, he also told me it definitely wasn't RA and that RA gets better when you're pregnant.

With her diagnosis still undetermined, the now-devastated and overwhelmed mother-to-be was in too much pain to work, so she quit and moved back in with her parents, because on top of all of this, her marriage had fallen apart.

I was on the couch for almost seven months, she says. The pain got better for about six weeks, between months seven and eight, says Baker. I finally felt better and hoped I was over it all.

It wasn't to be. The pain returned full force during her ninth and final month of pregnancy as she was also getting huge, she says. Almost sheepishly, she returned to her OB/GYN for pain relief. I didn't want anyone, including him, to think I was crazy.

That doctor told her: When you have the baby, you won't hurt anymore. Wrong: Her pain kept steadily increasing.

The calendar had flipped to 2006 now and the big day came to deliver. A c-section was complicated by my previous abdominal surgeries and resulted in a longer hospital stay and blood transfusions, Baker says. But my baby boy, Jackson, was healthy and I was thrilled!Still, her intense joint pain persisted. How would she manage being a single mother? Her doctor then told her: When you stop breastfeeding, you won't hurt anymore. But when she stopped after a year, her pain continued on.

I thought, If I just tough it out longer, I'll be OK, she says. I was pretty gullible, believing everything I was told.

Being a single mom is hard enoughbut fate would deal her another unlucky hand. Baker was worried: It seemed that Jackson, then 17 months old, was drinking constantly. Then one day he began stumbling, he couldnt see normally, and he'd been losing weight. She knew something was terribly wrong.

A doctor visit and blood tests showed his blood sugar was more than 750 mg/dL when he was diagnosed with type 1 diabetes. (Normal blood sugar for a person without diabetes ranges from between 70 and 100 mg/dL.) Frequent urination, thirst, fatigue, and weight loss are common symptoms of the disease.

He was too young to tell me what was wrong, how he was feeling, says Baker. His behavior changes and voice gave her clues as she tested his blood sugar regularly.

Baker was in nursing school by this time, still living with her parents and not working, except to play music part-time at a little, bitty job, she says.

In those first stressful weeks after his diagnosis, I'd stay up studying until 2 a.m., check my son, then sleep till 5 a.m. or 6 a.m. and then start it all over again, Baker says, knowing it was all worth it, even though then, it all felt almost unbearable.

I went through the roof at that time, Baker says, recalling seemingly insurmountable stress. Three weeks after her son's diagnosis, she finally saw her primary-care provider, where she wished she'd started, and tearfully confessed that she couldn't move her arms.

I couldn't even lift my baby. I'd have to scoop him, she says. I'd spend 30 minutes in the shower, in the warm water, to help get my arms moving in the morning, because they were 'locked' at a 90-degree angle.

The situation was terrifying. The baby relied on me for everythingme, the single mother trying to do everythingand I could barely take care of myself. I couldn't open a baby food jar, and didn't feel safe bathing him alone, Baker says. Thank goodness for my mother. But this was about survival, and I had to go on.

Her healthcare provider immediately did new blood tests for RA and he called Baker the same night to confirm positive results. "I was so glad to have an answer that I wasn't even devastated by that news," she says. The previously reported test resultsthe ones that ruled out RA while she was pregnantmust have been a mistake, she thinks now.

Her doctor quickly referred her to another rheumatologist who didn't just mumble and grunt at me, she says. He prescribed medication, and I started it in December 2007.

As for why Bakers OB/GYN had earlier ruled out RA because her symptoms continued during pregnancy, which, he said, was not the normit turns out he was half right and half wrong.

The latest research in UpToDate, an evidence-based clinical resource, says approximately 50% to 60% of pregnant women diagnosed with RA do have improvement in their symptoms, usually starting in the first trimester. And no, it's not possible to predict which patients will improve and which will flare.

Even more specifically, a review recently published in The Journal of Rheumatology reported that disease activity improved in 60% of patients with RA in pregnancy and flared in 46.7% postpartum. The Arthritis Foundation says that may be because of the hormone and immune system changes that protect an unborn child may also help RA.

The RA medication her doctor started her on was methotrexate, and it still stabilizes Baker's RA. It's a disease-modifying anti-rheumatic drug also known as a DMARD and it's considered a first-line treatment for RA. As the Johns Hopkins Arthritis Center shares, its benefits include that it works fairly quicklyin six to eight weeksit works well, is easy to use, and isn't expensive.

Bakers joints throbbed when she started taking it. She'd feel good for a few days, and then after the next week's injection, the pain would return. It took seven months before I started to feel normal, again, but a year later I was pretty much functional and able to play piano again! she says.

Baker has gone back and forth between methotrexate pills and now-weekly injections. She feels so much better now that she shudders to remember the two miserable years she spent with no pain medication except acetaminophen.

No one ever gave me any, she says. They just said: Everyone hurts when they're pregnant.

Jackson, Bakers now 13-year-old son, has clearly inherited his mother's indomitable, can-do attitude. His spirit is undefeatable, and he just bounces back with a resiliency that's amazing, Baker says of her son. His hasn't been an easy life and he makes it look so easy.

When Jackson doesn't feel well, he doesn't let it bother him. Instead he asks: "Can I go to school tomorrow? Baker patiently explains that he should rest and asks him to pace himself.

She homeschooled him until fifth grade and he thrived when he eventually attended school. Hes so motivated, just so driven, and wants to get into Harvard, she says. Hes also creative and talented and plays the lead in lots of school plays.

Getting to this point has meant thatmuch like his momJackson has had to overcome the awful moments that come with chronic illness. Baker recalls when, as a child, Jackson would say, I don't want to be diabetes, Mommy.

That was just heart-wrenching, Baker says. Now he's so calm, and he says to me: Diabetes isn't all that bad. There are more good things than bad things. That stumps me, and I just go blank, without a response.

He has said he doesn't quite understand it all, about why he hurts and can't get better, and why she hurts, too. Hes starting to assess when my hands and feet swell, and he says Im so sorry you have this rheumatism, she says.

Baker doesn't dwell on sorry, but stays active. She is part of the Diabetes Patient Advocacy Coalition that advocates for more affordable insulin. Shes been to Washington, D.C. three times in 2018 and 2019 to lobby her legislators to decrease the price of insulinand she intends to continue. As a partial result of the groups nationwide efforts, the Insulin Price Reduction Act was introduced July 22, 2019.

Baker isnt looking for a standing ovation, but she measures her lifes progress quietly every day, her eye firmly on the prizeand her goals.

With her pain controlled, and now her stress, Baker, who lives with her son, can focus on her accomplished life. She began that nursing degree in January 2008, around the time both she and her son were diagnosed with their diseases, and she finished in May 2010. Then in January 2019, she finished her masters degree in nursing and now works as a professor at a local university teaching the next generation of nurses. She will pursue her Ph.D. next, with the goal of becoming a university dean. Then there are more personal goals.

I want to be more active with my son when I can, Baker says. My body's getting physically stronger, and we're planning to do some runs together soon.

And theres travel. The pair plans to visit all 50 states. She's done 47, and Jackson has logged 10. Baker still plays music for therapy, not performing, but singing joyfully with her son in the car.

Shes relieved not to have to fight her body anymore. I'm trying to work with it instead of against it, she says. I dont accept it as: Boy, I love having this, but it's better than hating it all the time.

RA Reminds Her That Pain is Real, and Personal

Baker takes a whole-body approach to managing her RA. She consistently takes her medicationon timeand also likes to use essential oils for aromatherapy and for minor relief, applying them to her hands. To maintain her overall balance, she practices yoga, her favorite activity. She embraces deep breathing and calming apps on her phone, such as Calm and Headspace.

I do my part, and because I have a spiritual side, I leave the rest because I can't control it all, she says.

Baker remembers the time when doctors didnt hear her when she reached out for help with pain and she felt sheepish about pressing themnot so now. She encourages others with chronic illness to speak up for themselves. Youll experience a real difference between advocating and not, and if you dont find support in doctors you have, keep trying until someone really listens to you and works with you, she says.

It's made her a better nurse, especially when a patient shares about their pain. She learned in nursing school that pain is what the patient says it is. Baker knows this firsthand. Those months of gritting through intense pain during her pregnancy could have been shortened if only someone had really listened to her symptoms and pushed for treatment. Now Baker is doing the listening (and teaching) and her patients are lucky to have her.

See more helpful articles:

Let's Talk About Rheumatoid Arthritis

9 Conditions That Mimic RA

13 Supplements That Can Help Your RA

Read the original here:
Doctors Missed Her RA Symptoms in Pregnancy. She Found a Way to Thrive Anyway - HealthCentral.com

Read More...

Tai-Chi, Topical Capsaicin Among the New Treatment Recommendations for Osteoarthritis – Rheumatology Network

Friday, January 10th, 2020

The American College of Rheumatology (ACR), in partnership with the Arthritis Foundation, has issued treatment guidelines for osteoarthritis of the hand, hip and knee. This is the first update since 2012.

New in this release is the inclusion of patients in the decision-making process, which the Arthritis Foundation described a "patient-centric guidelines."

Traditionally, the patient voice has been invoked, but not always present, as guidelines are developed, said Guy Eakin, senior vice president of scientific strategy for the Arthritis Foundation. Through our partnership we were able to marry the ACR rheumatology expertise with the Live Yes! patient community to pioneer a process assuring guidelines that treat patients reflect the unique perspectives of the patients who will receive them.

The guidelines, which will be published in February in an ACR journal, emphasizes the adoption of basic therapeutic treatments which were strongly recommended. These include: weight loss; self-management programs to build fitness skills and exercise goalsetting. Previously consider conditions recommendations, the following were upgraded to strong recommendations: mind-body approaches such as tai-chi; topical NSAIDs for knee and hand osteoarthritis; oral NSAIDs and intra-articular steroids for knee and hip osteoarthritis.

Other recommendations include:

REFERENCE: Sharon L. Kolasinski, Tuhina Neogi, Marc C. Hochberg, et al. "2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee." January 2020. Arthritis Care and Research. DOI:10.1002/acr.24131

See the original post here:
Tai-Chi, Topical Capsaicin Among the New Treatment Recommendations for Osteoarthritis - Rheumatology Network

Read More...

Lyme disease: Justin Bieber’s tick-bite illness can cause joint pain, heart problems, and depression – The Conversation UK

Friday, January 10th, 2020

Justin Bieber recently announced that for the last couple of years hes been battling Lyme disease. Lyme disease, which is caused by the bacterium Borrelia burgdorferi, can be transmitted to humans if theyre bitten by an infected tick. In fact, its one of the most common tick-borne diseases in the west. An estimated 300,000 people in the US are diagnosed with it every year. The disease causes a range of debilitating symptoms, which can include severe headaches, neck stiffness, arthritis, joint pain and rashes. These symptoms can last for months or even years.

After being bitten, most people develop a red, circular rash, which may slowly expand beyond the bite site. Only around 20-30% of people will develop the characteristic bullseye rash. Without prompt treatment, the bacteria will spread from the bite site to tissues and organs, leading to additional skin lesions and a range of debilitating and persisting symptoms, such as pain, fatigue, memory problems and arthritis.

Perhaps alarmingly, instances of Lyme disease have actually become more common. In England and Wales the number of cases has increased from 1,134 in 2016 to 1,579 cases in 2017. The increase might be explained by a number of factors, including global warming (ticks survive better in warm weather) and increasing wildlife populations. Better diagnostic tools and increased awareness might also explain the surge in Lyme disease diagnoses.

Lyme disease can have a considerable impact on many aspects of the lives of the patient and their families. In severe cases, patients can be bedridden or wheelchair-bound for years without knowing if they will recover. Affected people may also experience anxiety, depression or distress, which can reduce their quality of life and deeply affect their mental wellbeing potentially even resulting in thoughts about suicide.

In most cases, a person will be diagnosed with Lyme disease based on whether they have the illnesss characteristic skin lesions especially if they live in an area where ticks carry Lyme disease. Although blood tests can also be used, these tests might only be 30-40% effective at detecting the disease in its early stages. But if the disease has already spread throughout a persons body, these results can be 100% accurate.

Giving a clear diagnosis of Lyme disease can be difficult, however. This is because many patients have a range of non-specific clinical symptoms, such as fatigue, malaise, headache, fever, sweats, joint aches and brain fog. Disease test results might also be similarly difficult to interpret, especially in patients that do not have the hallmark skin rash of Lyme disease and lack a recent history of exposure to tick bites. This makes dealing with the lingering infection difficult, especially where tests give inconclusive results.

In fact, people suffering from Lyme disease can also suffer from other tick-borne illnesses, such as babesiosis, which can be transmitted with Borrelia burgdorferi during the tick bite. This makes treatment even more complicated. As well, there is still some controversy about the right length of effective antibiotic therapy to treat patients with persistent, chronic Lyme disease. As a result, patients can, and usually do, feel helpless amid conflicting medical advice in fighting the disease.

Lyme disease is primarily treated with antibiotics. Early skin lesions and symptoms can be treated with the oral antibiotic doxycycline, usually for anywhere between ten to 21 days. Patients with neurological symptoms (including meningitis and encephalitis), heart inflammation or arthritis, are usually treated with a two-week course of intravenous ceftriaxone therapy. In most cases, timely diagnosis and prompt antibiotic treatment can improve symptoms.

But a misdiagnosis or late diagnosis can result in long-term illness, excessive use of antibiotic therapy, and expensive healthcare costs. Ignorance of the complex nature of this illness, especially the associated mental health issues, will further delay recovery. Dealing with these psychosocial problems regardless of whether they were triggered by Lyme bacteria or not can complement treatment and promote a quicker recovery.

Continued research and awareness about Lyme disease will be important for improving treatment and diagnosis. Developing more reliable diagnostic tests, identifying which patients are most likely to benefit from which antibiotic treatments, and taking measures to control tick populations will all be important for reducing instances of this disease in the future.

People can cut down on their risk of contracting Lyme disease by covering their skin in tall, grassy, wooded areas where disease-carrying ticks thrive. If you think youve been bitten by a tick, contact a doctor or health professional.

Excerpt from:
Lyme disease: Justin Bieber's tick-bite illness can cause joint pain, heart problems, and depression - The Conversation UK

Read More...

Cannabinoids in Medicine Part 3: Psoriasis and Rheumatoid Arthritis – Open Access Government

Friday, January 10th, 2020

Endocannabinoids, as well as several phytocannabinoids, have been shown to influence immune functions, regulating inflammation, autoimmunity, antitumourigenesis, antipathogenic responses and other processes.1 Numerous in vitro and in vivo studies have examined the therapeutic potential of cannabinoid signalling in inflammation-associated diseases (e.g. psoriasis) and attempted to dissect the complex immunological effects of cannabinoids.

Psoriasis is a chronic inflammatory disease of the skin, characterised by excessive proliferation of keratinocytes that results in the formation of thickened scaly plaques, itching and inflammatory changes of the epidermis and dermis.2 The underlying pathophysiology involves activation of classes of T-cells and their interaction with dendritic cells and other cells of the innate immune system, including neutrophils and keratinocytes.3

The following pre-clinical studies support the use of cannabinoids in the treatment of psoriasis:

A 2003 study in Journal of Clinical Investigation demonstrated that the cannabinoid receptors CB1 and CB2 are present in human skin cells, including keratinocytes;4

A 2003 study showed that anandamide, an endogenous CB receptor ligand, inhibits epidermal keratinocyte differentiation (abnormal keratinocyte differentiation is a hallmark of psoriasis);5

In 2004, a study in the Journal of Neuroimmunology used an in vivo mouse model to show that THC can shift the development of the predominantly pro-inflammatory T helper 1 (Th1) cell to the more anti-inflammatory (Th2) cell type profile;6

A 2007 study, published in the Journal of Dermatological Science, demonstrated that a range of cannabinoids inhibit keratinocyte proliferation in hyperproliferating human keratinocyte cell lines.7 The cannabinoids inhibited keratinocyte proliferation in a concentration-dependent manner. The activity of CBN (not significantly active at CB1/CB2 receptors) indicates more than one mechanism of action;

In 2011, a study using human cultured keratinocytes and a skin organotypic culture model, provided evidence that anandamide markedly suppresses keratinocyte proliferation and induces cell death, both in vitro and in situ. The cellular actions were mediated by CB1 and transient receptor potential vanilloid-1 (TRPV1). The cellular effects of anandamide are most probably mediated by Ca2+ influx and intracellular accumulation via the non-selective, highly Ca2+-permeable ion channel TRPV1. The study was published in the Journal of Investigative Dermatology;8

A 2016 study, published in the Annals of Dermatology, investigated the effect of CB1 agonists on mast cell activation. The authors found that CB1 agonists inhibited the release of inflammatory mediators and markedly and dose-dependently suppressed cell proliferation.9

RA is one of the most prevalent autoimmune diseases and one of the main causes of disability globally, causing pain, joint malformation and joint destruction.10 Preliminary evidence suggests that cannabinoids have a role in the future treatment of RA.

In one study,11 protein and mRNA expression of endocannabinoids, AEA and 2-AG, and cannabinoid receptors, CB1 and CB2, were found in synovial tissue obtained from 13 patients diagnosed with RA and undergoing arthroplasty whilst synovial tissue obtained from healthy volunteers was negative for the same endocannabinoids. Another study of synovial tissue from patients with RA12 found that of inflammatory cytokines, IL-6 and IL-8, which are stimulated by synovial cells, were attenuated by low concentrations of the synthetic cannabinoid WIN 55,212-2.

Furthermore, three different research groups achieved improvement in mice with collagen-induced arthritis (CIA), following treatment with various cannabinoids;13 The use of cannabinoids for the treatment of pain associated with RA has been assessed in only one 2006 clinical trial, where 58 patients with RA were allocated either nabiximols or a placebo.14 Compared with placebo, patients treated with nabiximols exhibited decreased pain along with improved sleep quality.15

1 Olh, A., et al. (2017) Targeting Cannabinoid Signalling in the Immune System: High-ly Exciting Questions, Possibilities, and Challenges. Front Immunol 8:1487.2 Habif, TP. (2016) Psoriasis and other papulosquamous diseases. Clinical Dermatology. 6th ed. Philadelphia, PA: Elsevier 263-328.3 van de Kerkhof, PCM and Nestl, FO (2018) Dermatology. 4th Edition, By Bolognia, JL., et al. 8, Psoriasis 138-160.4 Casanova, ML., et al. (2003) Inhibition of skin tumour growth and angiogenesis in-vivo by activation of cannabinoid receptors. J Clin Invest 111:43-50.5 Maccarrone, M., et al. (2003) The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem 278:33896-33903.6 Klein, TW., et al. (2004) Cannabinoid receptors and T helper cells. J Neuroimmunol 147:91-94.7 Wilkinson, JD., et al. (2007) Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J Dermatolog Sci 45:87-92.8 Tth, BI., et al. (2011) Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J Invest Dermatol 5:1095-104.9 Nam, G., et al. (2016) Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model. Ann Dermatol 28(1):22-9.10 Shapira, Y., et al. (2010) Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 6:468476.11 Richardson, D., et al. (2008) Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 10(2):R43.12 Lowin, T., et al. (2016) The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets. J Inflamm 13:15.13 Malfait, AM., et al. (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 97:95619566; Fukuda, S., et al. (2014) Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis. BMC Musculoskelet Disord 15:275; Gui, H., et al. (2015) Activation of cannabinoid receptor 2 attenuates synovitis and joint destruction in collagen-induced arthritis. Immunobiology 220:817822.14 Blake, DR., et al. (2006) Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology 45:5052.15 Blake, DR., et al. (2006) Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology 45:5052.

*Please note: This is a commercial profile

Editor's Recommended Articles

Here is the original post:
Cannabinoids in Medicine Part 3: Psoriasis and Rheumatoid Arthritis - Open Access Government

Read More...

Chilled to the bone the link between cold weather and joint pain – StarNewsOnline.com

Friday, January 10th, 2020

By Max Shenin, DO

WednesdayJan8,2020at6:01AM

Editors Note: This article is made possible through a sponsored content partnership with New Hanover Regional Medical Center.

Chilled to the bone. Many of us have used this expression after spending some time outdoors in the cold weather. But it leads to perhaps one of the most common questions posed to all rheumatologists: Does the weather have any impact on our bones or joints? Many people are convinced that they are able to predict the weather based on increase in joint or back pain. A commonly quoted study conducted more than 10 years ago seemed to support this notion by showing that every 10-degree drop in temperature as well as a drop in barometric pressure can increase joint pain.

The Arthritis Foundation even provides an arthritis index on its website that is based on local temperature and barometric pressure that anyone can use if they chose. So mystery solved, right?

Not so fast. Like so many things in medicine, our knowledge is always evolving. One of the more recent and largest studies to date found absolutely no connection between changes in weather and joint pain. This conclusion was based on very comprehensive data collected from over 10 million doctor visits. And then there was another recent Dutch study that showed an increase in barometric pressure and humidity correlated well to increased joint pain, which directly contradicted the previous notion that the drop in barometric pressures was the culprit for your achy bones.

Digesting all of these conflicting findings can be a challenge for clinicians and patients alike. The reality is that the verdict is likely still out on this complex issue and there is more data to come. Until we get some more clarity, my recommendation is to go with whatever your body tells you. After all, no science can compete with personal experience that tells you that the ache you feel in your knees probably means that you should get your umbrella ready.

Dr. Max Shenin is a board-certified and fellowship trained rheumatologist with NHRMC Physician Group Rheumatology. To make an appointment, call 910.662.7550.

More here:
Chilled to the bone the link between cold weather and joint pain - StarNewsOnline.com

Read More...

CBD Technology and How CBD Patches Are Helping People – HealthTechZone

Friday, January 10th, 2020

Thanks to the advancement in technology, it seems like CBD is making its way into everything nowadays. The list of CBD-infused products includes intimate gels, sparkling water, chocolate, gummies, shampoo, skin creams, coffee, and so much more. One of the latest addition to the list is CBD patches.

As you probably already know, patches have been existing for many years already and are famous for effectively delivering healthy ingredients into the bloodstream. Today, its now getting utilized as a vehicle for CBD to get into your body and help you enjoy the benefits of the chemical.

The Technology Behind How CBD Patches Are Created

The technology used in creating CBD patches has already been around for decades, despite the product being relatively new in the market. The technological concept is much similar to birth control or nicotine patches, added with a couple of twists to ensure that the patch can deliver CBD to the bloodstream effectively.

CBD patches contain a dose of Cannabidiol molecules, infused in an isolated oil, gel, or solution. They also have carriers and permeation enhancers, and because your skin has a low CBD concentration, the high concentration of the patch moves the Cannabinoid into your body.

CBD patches and their transdermal application continue to become famous as an alternative way to reap all the benefits that CBD supplements bring to the table. Many people also view it as a way to receive a prolonged treatment dosage while being discreet.

Like any other CBD-infused products available in the market today, CBD patches cant get you high since Cannabidiol functions differently than THC, the psychoactive element of Cannabis plants. Accurate, useful, and comfortable, CBD patches are as simple as they sound, even if the technological process they undertake is a bit complicated.

This post will help you take a closer look at CBD patches, how these products work, and how they can help people.

Whats A CDB Patch And How Does The Product Work?

If you want to picture out what CBD patches look like, you only have to imagine large band-aids since theyre very closely similar in appearance. Also, like a large band-aid, you can peel and stick a CBD patch to any location in your body. The only difference is that the CBD patches are pieces of plastic infused with Cannabidiol.

Unlike the typical CBD oils, the patches arent wet. Theyre dry so they can stick to your skin. Most users place them on venous parts of the body, including their arms, ankles, and wrists. They do this since those areas have the potential for a higher absorption rate of CBD into the bloodstream.

Cannabidiol patches function by following a complex chemical reaction with the users body. Your body heat will activate the pieces and causes them to release CBD molecules and other ingredients that they contain. Please take note that in addition to Cannabidiol, some patches may contain caffeine, melatonin, THC, and more. Once these molecules get absorbed through the skin, they make their way into the bloodstream, where the body can start processing the compounds. After that, youll then begin to experience the benefits of CBD.

Benefits of CBD Patches

One of the essential benefits of CBD patches is the efficient delivery of Cannabinoid to the body. However, there are other equally important benefits, as well.

Here are some benefits of CBD patches:

1. Better Compound Absorption - Whats the reason behind CBD patches better absorption? It starts with the fact that your lungs and stomach are excellent at preventing any chemical from entering your bloodstream, which is how other CBD products, such as vape and gummies, enter. While its great that such a defense mechanism is possible to protect your body when youve inhaled or ingested something harmful, it also means that anything beneficial that youve consumed may reach your cells with limited effects.

By using CBD patches, you can bypass the filtering organs of your body, so more of the compound makes it into the bloodstream. It results in less CBD needed for you to feel and experience the benefits of the chemical.

2. Pain Management - CBD patches, like other CBD-infused products, have shown to alleviate ailments-related pains in the body, including lower back pains, spinal cord injury, arthritis, cancer, multiple sclerosis, muscle spasms, chemotherapy, and depression.

You can use CBD patches to manage both acute and chronic pains. Like band-aids, youll have to apply the patch to the site or area where you feel pain, allowing the supplement to get delivered immediately or over a short period.

Some CBD patches can also last for three days through nanotechnology in the reservoir patch, so its best to weigh your options based on your needs.

3. Arthritis - One of the leading causes of disability in the USA is arthritis. More than fifty-four million adults in the country have arthritis, which is more common in women than men. One type of arthritis, osteoarthritis, affects thirty-one million in the country by causing joints inflammation.

Several studies have pointed out the effectiveness of transdermal doses of CBD to reduce pain and other symptoms related to arthritis.

Final Thoughts

Many CBD users prefer transdermal delivery because it can bypass the stomach, liver, and lungs entirely - the traditional organs that break down or filter the Cannabinoid. So, such a method of taking Cannabidiol can give you at least fifty percent up to one hundred percent of the value of the supplement.

Kyle Tresch

Kyle Tresch is a pharmaceutical scientist who researches the efficacy of new drugs and medicines. Kyles responsibilities include discovering new compounds that can treat certain illnesses, development of these compounds to assess its safety and efficacy among human beings, and the manufacture of these compounds into drugs for public consumption.

Kyle shares his expertise by contributing articles to various platforms online.

Continue reading here:
CBD Technology and How CBD Patches Are Helping People - HealthTechZone

Read More...

Upcoming events Pfizer’s abrocitinib and Myovant’s relugolix – Vantage

Friday, January 10th, 2020

Welcome to your weekly roundup of approaching clinical readouts.Pfizers Jak 1 inhibitor abrocitinibwill need to prove itself against the dermatitis stalwart Dupixent in the phase III Jade-Compare trial, data from which aredue shortly. It is already known that abrocitinib works in atopic dermatitis, sinceit met key endpoints in two phase III trials. But the safety profile will need to beclosely analysed; Jak inhibitors have had to contend with serious toxicities when used in rheumatoid arthritis.

Abrocitinib is said to be selective for Jak 1, which investigators believe reduces the risk of class-related adverse events such as infections and thromboembolic and other cardiovascular events.

In abrocitinibs previous atopic dermatitis studies,Jade Mono-1 and 2, the rate of serious adverse events was 2-3% in treated patients, anddiscontinuations were in the 4-6% range, higher than the 2% previously seen with Dupixent. There were no thromboembolic events with Pfizers Jak, but there seem to be tolerability issues judging by the 10-20% rate of nausea and headache. In Dupixent studies the most frequent adverse eventswere injection site reactions and conjunctivitis.

In terms of efficacy the higher dose of abrocitinib showed comparable results to Dupixent in its pivotal trials. In the latest study, Jade-Compare, abrocitinib is pitted directly against Dupixent in adults on topical background therapy. Again 100mg and 200mg daily doses of abrocitinib are being tested, and the co-primary endpoints are investigators global assessmentand EASI-75 score at 12 weeks.

On Pfizers third-quarter call management specifically pointed to a secondary endpoint, pruritus reduction, where the company expects abrocitinib to outperform, as it inhibits the interleukin-31 that is a major itch mediator, which is not covered by Dupixent.

Displacing Dupixent will be tough given physicians' experience and the potential for a black-box warningfor abrocitinib, in common with other Jaks. OnPfizers side will be convenience: abrocitinib is oral and Dupixentsubcutaneous.

In terms of Jak competition Lillys Olumiant and Abbvies Rinvoq are in phase III trials in atopic dermatitis and approved,with black box warnings, in rheumatoid arthritis. Meanwhile, Dermira has just been bought by Lilly (Lilly jumps the gun with Dermira deal, 10 Jan 2020).

Myovant looks for Spirit guidance

For Myovant Sciences phase III endometriosis data due by the end ofthe second quarter will not just be about scoring a clinical win with its GnRH inhibitor relugolix; they will alsohopefully showsome benefit over the approved market leader, Abbvies Orilissa.

Relugolix has previously disappointed relative to expectations in cross-trial comparisons with Orilissa in uterine fibroids. And on its current development trajectory, even if the Spirit 1 and Spirit 2 trials are successful, the project will hit the market two and a half years after Orilissa. Strong data will be essential if Myovant is to stand any chance of taking market share from the pharma giant.

Relugolix and Orilissa both work by blocking the gonadotrophin hormone and reducing the pain associated with endometriosis, a disorder where tissues that usually line the wall of the uterus grow outside of the womb.

However, where Orilissa is used asa monotherapy, the Spirit trials are testing relugolix in combination withan oestrogen"add-back therapy". One of the biggest side effects of GnRH antagonists isbone loss, whichcan limit the duration of treatment. Add-back therapy can thus extend the treatment window for what is a chronic disease.

Myovant supporters have highlighted this as an advantage over Orilissa, alongside relugolixs dosing convenience. But Abbvie could hobble this advantage with results from a 681-patienttrialcomparing Orlissa monotherapy against a combination with hormoneadd-back. If thistrial is positive Leerink analysts say alabel extension for Orilissa could follow in the third quarter, six months beforerelugolixs forecast endometriosis approval.

With so much stacked up against Myovant it is not surprising that 2024 sales forecasts for relugolix in endometriosis are only $278m, compared with $843m for Orilissa, according to EvaluatePharma. The Spirit data will have tosurprise for Myovantto avoidbeing an also-ran in the indication.

Originally posted here:
Upcoming events Pfizer's abrocitinib and Myovant's relugolix - Vantage

Read More...

Prolotherapy Is a Great Treatment for Arthritis – Jewish Link of New Jersey

Friday, January 3rd, 2020

Prolotherapy is the use of a solution that helps grow stronger ligaments and tendons. Arthritis is considered a joint problem but the pain from arthritis is often caused by the surrounding soft tissue, which consists of these ligaments and tendons. Because of this, prolotherapy is a great treatment for a wide range of arthritic conditions. If you have arthritis, you have the opportunity to greatly benefit from prolotherapy.

Ligaments hold together bones. Around a joint they blend together to form a joint capsule. Tendons are said to connect muscles to bones, but it is more accurate to say that tendons are the continuation of the muscles that help connect the muscles to bones. This connection helps the muscles move the bones. The problem for both ligaments and tendons is that they do not get much blood flow. The difference in blood flow between the muscles and tendons and ligaments is highlighted by their color differences. Muscles are red with good blood flow, while ligaments and tendons are yellow-white, suggesting poor blood flow. So when they are injured, ligaments and tendons do not heal well. This contrasts with muscle which, when injured, tends to heal very well, often in four to six weeks.

Joint arthritis is thought of as the wearing out of bones that are connected. A common example is the knee joint. An x-ray of knee arthritis shows that the bones are closer together, called joint space narrowing (or on the spine, called disc space narrowing). Also seen on x-rays are bone spurs that grow off the bone. What is not well visualized on x-ray are ligaments and tendons. It is important to understand that loosening of ligaments plays a key role in the development of arthritis. Also, much of the arthritic pain is from the ligaments and tendons around the joint. By strengthening the ligaments and tendons with the prolotherapy solution, the arthritic pain can dramatically improve. Even when knee arthritis is severe, as in bone-on-bone, the pain can improve with prolotherapy. That is because much of the pain is coming from the ligaments and tendons, and even with severe arthritis the tendons and ligaments respond well to prolotherapy.

As a general rule, bone spurs result from loose ligaments. When a ligament is loose, the joint has intrinsic instability. Sometimes the instability is severe that the joint slips out of place. More often, there is mild laxity (looseness) such that the bones mildly rub against one another. In reaction to this physical stress, bone spurs develop as a way for the bone to protect itself. While the bone spur can cause some stiffness with movement, it usually does not cause pain. However, the unhealthy ligaments can cause significant pain. By improving the strength of the ligament, the joint pain will subside. When joint movement is affected by arthritis, the tendons also bear stress with the abnormal movement. These weakened tendons also produce pain. When the tendons are strengthened, the pain is significantly improved.

The shoulder is the most mobile joint in the body, so it is susceptible to arthritis. While they are considered different conditions, rotator cuff tendonitis and shoulder arthritis result from a similar cause. The rotator cuff is a group of four muscles that wrap around the shoulder like a cuff. By its name you can guess that the rotator cuff helps rotate the shoulder. Just as important, the cuff helps stabilize the shoulder, helps keep the shoulder joint in place when the arm is moving. When the ligaments weaken, this puts stress on the shoulder joint so bone spurs form and arthritis develops. At the same time, when the ligaments weaken, the rotator cuff muscles have to work harder. The cuff muscles then become strained, eventually progressing to a tear. Thus, rotator cuff injuries and arthritis form as part of this process. The good news is that because both problems involve ligament laxity and weak tendons, both conditions respond very well to prolotherapy.

Hips and knees are the key weight bearing joints so they are also vulnerable to arthritis. By strengthening the ligaments and tendons around knees and hips, the pain improves. Hands include our most used joints so they are also very susceptible to arthritis. Because they get so much use, the finger joints become stiff, painful and even deformed. While prolotherapy will not necessarily reverse the deformity, arthritic hand pain responds beautifully to prolotherapy. This is because the hand pain is caused by very small tender ligaments which are strengthened by prolotherapy.

While arthritis in the spine has different names including stenosis, spondylosis, facet syndrome and degenerative disc disease, they all have a similar underlying cause: lax ligaments. Even disc herniations are related to lax ligaments. Discs are sandwiched by the vertebrae (spine bones) and are made of fibrous tissue with a central gel-like substance. When the ligaments weaken, the vertebrae lose their support. This increases disc pressure, so the disc fibers weaken, eventually herniating or falling out. When the disc compresses the nerve, severe leg pain results, otherwise known as sciatica. As the discs wear out, the space between the vertebrae narrows, with bone spurs forming. This leads to the typical arthritic spine pain, known by the various names described above. This process is similar in the cervical spine (neck) and lumbar spine (low back). The key to understanding this is that it is lax ligaments which are a strong contributor to all these conditions. This is why prolotherapy is so effective for neck and back pain conditions.

Another key aspect of prolotherapy that complements its effectiveness is that it is very safe. As opposed to a steroid injection, which suppresses body functions and has to be limited due its toxicity, prolotherapy stimulates the bodys healing reactions so it can be repeated, if necessary, and can be used for multiple areas of pain. As opposed to arthroscopy, which treats arthritic pain by cutting away loose tissue fragments and bone spurs, prolotherapy treats arthritic pain by building and strengthening tissue for long-term healing.

In summary, prolotherapy is a great treatment for arthritis affecting multiple joints, including the most commonly affected joints such as the shoulders, hips, knees and fingers, and even less commonly affected joints such as the elbows, wrists, ankles and toes, and also anywhere along the spine including the neck and low back. The reason it is so effective for arthritis is because the pain caused by arthritis is often caused by lax ligaments and these ligaments are strengthened by prolotherapy. Please check my website where I describe the logistics of prolotherapy (Prolotherapy Info) and go into more detail about how prolotherapy works (How Prolotherapy Works).

Dr. Slaten is a pain wellness physician in Ridgewood. For more than 20 years, he has been practicing with great skill and an open mind. Learn more about prolotherapy and his other treatments at his website, http://www.njprolo.com.

More:
Prolotherapy Is a Great Treatment for Arthritis - Jewish Link of New Jersey

Read More...

The Oldest Polar Bear in the World Likely Lives in Tacoma – 425magazine.com

Friday, January 3rd, 2020

While most polar bears live only to their mid-20s, Boris recently celebrated his 34th birthday, meaning hes probably the oldest male polar bear on the planet, and hes living out his best retirement years at Point Defiance Zoo & Aquarium after living treacherously with a traveling circus.

At 11:01 a.m. on an unseasonably warm morning, Point Defiance Zoo & Aquarium staff biologist Cindy Roberts exited the backstage area of the zoos polar bear exhibit and arrived moments later in the public viewing area for her two furry, white charges.

My name is Cindy, Im a staff biologist, and Im lucky enough to work with our two polar bears, Roberts said with an energetic smile as she addressed the families that had accumulated in front of the exhibit.

We have Blizzard, who is our younger bear; he is going to be 24 years old, Roberts continued. And we also have Boris, who is our really old bear; he (turned) 34 on Dec. 15th.

Blizzard was standing just beyond the exhibits saltwater pool. Elsewhere, hidden from the view of the crowd, Boris lounged indoors with his hind legs spread straight out behind him as he laid on the floor and pawed languidly at an ice treat fillets of salmon in a block of ice in front of him.

The 873-pound-bear is perfectly content, and despite some common elderly issues skin and liver problems, arthritis, and bad teeth from years of mistreatment hes living a happy, healthy life.

Prior to coming to Point Defiance in the early aughts, Boris lived a storied life with two circus productions. He was born in a German zoo in the mid-1980s, and at 18 months old, started performing with Ursula Bttcher, one of the most celebrated female animal trainers in the world, who was particularly famous for performances with polar bears.

She took care of those bears very well for that time period, Roberts said of the research shed done on Bttcher and her act. If she thought anyone was harming them in any way, she would fire them instantly.

However, after the fall of the Berlin Wall and the unification of Germany in 1989, the state-run East German circus that effectively owned Boris began to be phased out, and by the late 1990s, the bears had been sold. Some remained in Europe, but most were sold to the Suarez Brothers Circus in Mexico.

The Suarez Brothers badly mistreated the bears, feeding them a feeble diet of bread and lettuce and housing them in small cages without room to swim or cool off. The bears were eventually seized by American authorities after the zoo traveled to Puerto Rico a U.S. territory.

A YouTube video taken around the time of the bears seizure shows the massive mammals crammed into small cages atop a trailer. The bears were panting, drooling, and swaying side to side in an attempt to cool themselves.

Our vet at the time, Dr. Holly Reed she has since passed away she actually transported the bears to the U.S., and they were in pretty bad shape, Roberts said. We got Boris and Kenny the other bears went to Baltimore, Detroit, and North Carolina.

Though Roberts was not at the zoo when Boris arrived, she has now worked with him for more than a decade, and he holds a special place in her heart.

Hes just an amazing animal because of his history, she said. I think not only does (his story) give us all passion for polar bears in general, but it gives us hope in facing challenges and getting to the other side where you get salmon treats and you dont have to go outside.

Born: Dec. 15, 1985

Weight: 873 pounds

Height: 5 feet

Diet: Raw ground meat, fish, beef fat, and specially formulated kibble

Pounds of food per day: 7.5 to 21

Medication: 134 pills a day

Fun fact: He was the first polar bear to receive a stem cell transplant, to help lessen the effects of his arthritis.

Save the date

Interested in learning about how to help polar bears like Boris live long, healthy lives? Consider attending the zoos annual Party for Polar Bears, presented by the Point Defiance Chapter of the American Association of Zookeepers from 5 to 9 p.m. on Feb. 24, at Dystopian State Brewing in Tacoma. More information here.

Originally posted here:
The Oldest Polar Bear in the World Likely Lives in Tacoma - 425magazine.com

Read More...

Psoriatic Arthritis Treatment Market Advance Technology And New Innovations 2020 To 2025 -Eli Lilly, Roche, Merck, Novartis – Market Research Sheets

Friday, January 3rd, 2020

The report titled Global Psoriatic Arthritis Treatment Market Size, Status and Forecast 2019-2025 provide (6 Year Forecast 2019-2025)enhanced on worldwide competition by topmost prime companies (Eli Lilly, Roche, Merck, Novartis, Abbvie, Amgen, Bristol Myers Squibb, Celgene Corporation, Janssen, Valeant Pharmaceuticals) which providing information such asCompany Profiles, Capacity, Gross, Gross Margin, Product Picture and Specification, Production, Price, Cost, Revenueand contact information. This Psoriatic Arthritis Treatment market report crucial insights that facilitate theMarket Trends, Drivers, Market Dynamics, Overview, Scope, Definitions, Classifications, Opportunities, Competitive Landscape. The report provides key statistics on the market status of the Psoriatic Arthritis Treatment market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Get Free Sample PDF (including full TOC, Tables and Figures)of Psoriatic Arthritis Treatment [emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2237281

Target Audience of Psoriatic Arthritis Treatment Market :Key Consulting Companies & Advisors, Production Companies, Suppliers,Channel Partners, Marketing Authorities, Subject Matter Experts,Research Institutions, Financial Institutions,Market Consultants, Equipment Suppliers/ Buyers, Industry Investors/Investment Bankers Government Authorities.

Scope of Psoriatic Arthritis Treatment Market:The report affords a basic outline of the Psoriatic Arthritis Treatment Market report contains definitions, competitive landscape evaluation, segmentations, applications, key providers, market drivers and challenges. The Psoriatic Arthritis Treatment Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data.

On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-

Kits Reagents Instruments

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Psoriatic Arthritis Treatment market for each application, including-

Hospitals Clinics Ambulatory Surgery Centers Diagnostic Laboratories

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2237281

Psoriatic Arthritis Treatment Market: Regional Analysis Includes:

The Psoriatic Arthritis Treatment Market Report Can Answer The Following Questions:

What is the (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Psoriatic Arthritis Treatment market?

Who are the key manufacturers of Psoriatic Arthritis Treatment market? How are their operating situation (capacity, production, price, cost, gross and revenue)?

What are the upstream raw materials and manufacturing equipment of Psoriatic Arthritis Treatment? What is the manufacturing process of Psoriatic Arthritis Treatment?

Economic impact on Psoriatic Arthritis Treatment industry and development trend of Psoriatic Arthritis Treatment industry.

What will the Psoriatic Arthritis Treatment market size and the growth rate be in 2025?

What are the key market trends impacting the growth of the Psoriatic Arthritis Treatment market?

What are the Psoriatic Arthritis Treatment market challenges to market growth?

What are the Psoriatic Arthritis Treatment market opportunities and threats faced by the vendors in the Psoriatic Arthritis Treatment market? Etc.

Contact:

ResearchMozMr. Nachiket Ghumare,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email:[emailprotected]

Browse More Reports Visit @https://bit.ly/2Sepby2

This post was originally published on Market Research Sheets

See the rest here:
Psoriatic Arthritis Treatment Market Advance Technology And New Innovations 2020 To 2025 -Eli Lilly, Roche, Merck, Novartis - Market Research Sheets

Read More...

Development and validation of a clinical rule for recognition of early inflammatory arthritis. – DocWire News

Friday, January 3rd, 2020

This article was originally published here

Development and validation of a clinical rule for recognition of early inflammatory arthritis.

BMJ Open. 2019 02 22;8(11):e023552

Authors: Ten Brinck RM, van Dijk BT, van Steenbergen HW, le Cessie S, Numans ME, Hider SL, Mallen C, van der Helm-van Mil A

AbstractOBJECTIVES: National and international guidelines recommend prompt referral of patients presenting with inflammatory arthritis (IA), but general practitioners (GPs) feel uncertain in their proficiency to detect synovitis through joint examination, the method of choice to identify IA. Our objective was to develop and validate a rule composed of clinical characteristics to assist GPs and other physicians in identifying IA when in doubt.DESIGN: Split-sample derivation and validation study.SETTING: The Leiden Early Arthritis Recognition Clinic (EARC), a screening clinic for patients in whom GPs suspected but were unsure of the presence of IA.PARTICIPANTS: 1288 consecutive patients visiting the EARC.PRIMARY AND SECONDARY OUTCOME MEASURES: Associations of clinical characteristics with presence of IA were determined using logistic regression in 644 patients, while validating the results in the other 644 patients (split-sample validation). To facilitate application in clinical practice, a simplified rule (with scores ranging from 0 to 7.5) was derived and validated.RESULTS: IA was identified by a rheumatologist in 41% of patients. In univariable analysis, male gender, age 60 years, symptom duration <6 weeks, morning stiffness >60min, a low number of painful joints (1-3 joints), presence of patient-reported joint swelling and difficulty with making a fist were associated with IA in the derivation data set. Using multivariable analysis, a simplified rule consisting of these seven items was derived and validated, yielding an area under the receiver operator characteristic curve (AUC) of 0.74 (95% CI 0.70 to 0.78) in the derivation data set. Validation yielded an AUC of 0.71 (95% CI 0.67 to 0.75). Finally, the model was repeated to study predicted probabilities with a lower prevalence of inflammatory arthritis to simulate performance in primary care settings.CONCLUSIONS: Our rule, composed of clinical parameters, had reasonable discriminative ability for IA and could assist physicians in decision-making in patients with suspected IA, increasing appropriateness of healthcare utilisation.

PMID: 30798292 [PubMed indexed for MEDLINE]

Go here to read the rest:
Development and validation of a clinical rule for recognition of early inflammatory arthritis. - DocWire News

Read More...

SARS can cause arthritis and gout – The Saxon

Friday, January 3rd, 2020

Few people know that the seasonal SARS hides more dangers than it seems. Incorrect or incomplete treatment of the common cold can affect the human body severe pain with every movement because of the infection of the joints.

Getting arthritis or gout possible due to seasonal and SARS, which often suffer from fall and winter. The common cold will develop into pain and deformity of the joints, if you just ignore it or MIS treated. Its all in the bloodstream, which carries the infection throughout the body from the affected areas. Weakened by the struggle with a cold, the immune system literally can miss the infection of the joints, especially if the person recently stood in the cold or got hypothermia.

To lose joints possible not only after you sneeze or cough, but promiscuous sex and urinary tract infection. The infection acts on the same principle that SARS travels through the bloodstream and infects cartilage, bringing the man down. Such rogue infection develops reactive arthritis, a dangerous disease that is very difficult to diagnose.

Under threat and people in the reverse situation, when the immune system is working at 120% because of the medicine. He can be overzealous after the suppression of the disease, and begin to attack the cartilage of joints, causing rheumatoid arthritis. The disease quickly immobilizes a joint and switched on the nearby tissue, which is extremely dangerous.

The main danger of such a receiving arthritis in that it is extremely difficult to diagnose and successfully cure it is possible only at the initial stage (both diseases). Because doctors do not advise to delay going to the hospital, or instead of therapy and pills, the patient will have to lie on the operating table and undergo a long rehabilitation.

Maria Batterburyis a general assignment reporter at the Saxon. She has covered sports, entertainment and many other beats in her journalism career, and has lived in Manhattan for more than 8 years. Vivian has appeared periodically on national television shows and has been published in (among others) NPR, Politico, The Atlantic, Harpers, Wired.com, Vice and Salon.com..

Link:
SARS can cause arthritis and gout - The Saxon

Read More...

Page 40«..1020..39404142..5060..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick